In this ecumenically appealing book of faith planting and nurturing, by Dr. Joe Borowitz, I see a dance between Joe as a Sunday schoolteacher, other Sunday schoolteachers, and Sunday school students, their parents and the Church. Beginning on the personal level, Joe reaches out to the inter-personal. He privileges the personal level that emerges as author, professor, and moralist and shares suitable stories and life events. How powerful personal experiences can be! Dr. Joe underscores the primacy of God in human life, arguing that people function better when they have God at the center of their lives. He reminds us that the Resurrection is the most important event in human life. The Holy Spirit, he calls a superior "life force" that enlivens and sustains us. That all should welcome this book is thus obvious. To veteran teachers it will give a nostalgic feeling and satisfaction; to students in Sunday school and their parents, it will give a sense of dedication and direction as they embrace this journey of faith; and to the general reader both catholic and non-catholic it will bring to mind the place of CCD or Sunday school in faith planting. Rev. Dr. Cajetan Ebuziem Priest Chaplain St. Elizabeth Regional Health Lafayette, Indiana, USA.
New Treatments of Leukemia and Lymphoma describes the most important advances in the therapy of hematopoietic cancers that have been derived from recent discoveries in cancer cell biology, kinase biochemistry, and immunology. Detailed descriptions of the large number of new and effective agents that have recently become available for the treatment of leukemias and lymphomas as well as an understanding of their mechanisms of action and their integration into current therapy are provided. A number of experimental drug reagents currently in clinical investigation are also discussed. The therapies include conventional anti-metabolites, monoclonal antibodies directed to cell surface receptors, antibodies tagged with toxins and radiopharmaceuticals, inhibitors of specific kinases, stem cell transplants, and engineered T-cells designed to selectively target hematopoietic cancers. The contents of the book will allow practitioners and investigators alike to understand what is current and state of the art as well as what to look for in the future. * Provides an up-to-date, state of the art discussion of a rapidly changing field * Great breadth covering conventional chemotherapeutic agents, biologic agents such as antibodies, novel small molecule inhibitors and genetically engineered cells * Written by international experts in each of the fields
Thank you for visiting our website. Would you like to provide feedback on how we could improve your experience?
This site does not use any third party cookies with one exception — it uses cookies from Google to deliver its services and to analyze traffic.Learn More.